<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We treated 25 patients suffering from low-grade lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> with <z:chebi fb="0" ids="33838">nucleoside</z:chebi> analogues </plain></SENT>
<SENT sid="1" pm="."><plain>In 11 patients undergoing treatment with fludarabine, two patients with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> developed a marked absolute peripheral blood <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> devoid of clinical symptoms which resolved without medical intervention </plain></SENT>
<SENT sid="2" pm="."><plain>Of 15 patients treated with 2-chlorodeoxyadenosine, one patient with B-cell <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (CLL) experienced repeated episodes of <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> that required steroid treatment </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001880'>Eosinophilia</z:hpo> in these three patients was not coupled to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> lysis, and we found no correlation between the occurrence of <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> and clinical response to treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, for the first time, we can report <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> as a side-effect of fludarabine treatment, and these are also the first published cases of this complication occurring in patients treated with <z:chebi fb="0" ids="33838">nucleoside</z:chebi> analogues for follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and CLL </plain></SENT>
</text></document>